The importance of measuring kidney function rather than estimating when a decision can impact someone’s chance at receiving a life giving transplant. @AJBentall @MayoClinicNeph @MayoTransplant
Are we Asking the Right Questions When Assessing Glomerular Filtration Rate in Living Kidney Donors? @AJBentall
ovid.com/jnls/transplantjour…
DOI: 10.1097/TP.0000000000005926
Are we Asking the Right Questions When Assessing Glomerular Filtration Rate in Living Kidney Donors? ovid.com/10.1097/TP.00000000…
Hatem Amer, MD, FASN, FAST retweeted
I never thought WE will be doing this successfully in 2026!
“If you can dream it, you can do it.”
@MayoClinic
Hatem Amer, MD, FASN, FAST retweeted
Day 2 of @MayoClinicNeph 2026 Selected Topics in Glomerular Diseases & Kidney Pathology starting off with our fearless leader, Dr. Vesna Garovic, sharing opening remarks highlighting the impact of Mayo Clinic in the field of Nephrology, as well as upcoming courses. Stay tuned!
Superb lectures and interactive discussion. Cases were very educational.
Replying to @LeticiaRolonMD
Wrapping up the 1st day of the inaugural @MayoClinicNeph Selected Topics in Glomerular Diseases & Kidney Pathology course w/ a session on Vasculitis. 1st to the podium is Pulmonologist, Dr. Ulrich Specks speaking on updated tx of patients with AAV and severe renal involvement
Hatem Amer, MD, FASN, FAST retweeted
😊🙏🏻 Happy to share our newly published article in 📢💊
"Protocol-constrained AI enhances tacrolimus dosing accuracy in kidney transplant care"
🔗 Read the full open-access article here: doi.org/10.3389/frai.2026.18…
Tacrolimus dosing after a kidney transplant is highly complex, individualized, and prone to variability. To help address this, our team developed TacroDose AI—a protocol-constrained large language model (LLM) designed to generate dosing recommendations that strictly align with established institutional guidelines.
💡 Key Findings:
🔹 After refining our model with structured output verification (TacroAI 2.0), we achieved a remarkable 91.7% protocol adherence.
🔹 Crucially, we reduced sentinel errors to just 1.0% and significantly improved reproducibility.
🔹 This provides a powerful framework for integrating generative AI with rule-based clinical protocols to support safe, clinician-supervised medication management in transplant care.
A huge congratulations to my outstanding mentee and first author, Benjamin Bizer, and our fantastic fellows who drove this project! 👏✨ I am so incredibly grateful to collaborate with this brilliant team: Oscar A Garcia Valencia, Flora Kincses, Jose Arriola-Montenegro, Charat Thongprayoon, and Jing Miao, Wisit Cheungpasitporn. @josearriolam @OscarGarciaMD @jingmiao2019 @MayoClinicNeph @FrontiersIn
Wisit Cheungpasitporn, MD, FACP, FASN, FAST
Clinician-Scientist & Professor of Medicine, Mayo Clinic
Leading AI Innovation in Kidney Care
#KidneyTransplant #Nephrology #ArtificialIntelligence #GenerativeAI #Tacrolimus #DigitalHealth #ClinicalDecisionSupport #MedicalEducation #HealthcareAI #FutureOfMedicine #MayoClinic
Hatem Amer, MD, FASN, FAST retweeted
In this article I argue against using clinical remission as an endpoint for stopping IS therapy in lupus nephritis! There is a pro position, as well as moderator commentary. Hope you enjoy it! @asnpublications
journals.lww.com/kidney360/c…
Proud of our 2025-2026 transplant nephrology fellows. 2/5 young innovator awardees at CEOT. @MayoClinicNeph @MayoTransplant
Hatem Amer, MD, FASN, FAST retweeted
😃✨ Last Day of the KDIGO Controversies Conference on Technological Advancements to Support Guideline-Informed Care (20–23 November 2025, Madrid 🇪🇸) @goKDIGO
Today was an inspiring final day as we presented the refined summaries, integrated feedback across all eight questions, and continued shaping a cohesive synthesis for the conference report. We also engaged in focused discussions to map out the key research gaps and research priorities that will guide future work in technology-enabled, guideline-informed kidney care. 💡
🙏 We are grateful for the opportunity to collaborate with such an exceptional group of global colleagues whose insights and dedication continue to push the field forward. @FrancescoPesce
🤝 Looking ahead, we are excited for the continued partnerships, shared learning, and innovative projects that will emerge from this week.
@MayoClinicNeph
Conference link 🔗
kdigo.org/wp-content/uploads…
Hatem Amer, MD, FASN, FAST retweeted
No better way to end the #DLE2025 in Egypt 🇪🇬 than chairing this amazing inspirational lecture by former @ASTSChimera president Dr. Lloyd Ratner from @ColumbiaSurgery on innovation and transforming transplantation . Now back to the 🇺🇸 @h4amer @CleClinicUro #kidney #transplant
Hatem Amer, MD, FASN, FAST retweeted
Dr Pablo Moreno presenting on donor care units. @MayoTransplant @PabloMorenoGar6
Dr Pablo Moreno presenting on donor care units. @MayoTransplant @PabloMorenoGar6
Dr Martin Mai presenting on the evolution of kidney allocation in the US. @MayoTransplant @MayoClinicNeph @DonateLifeEG @PabloMorenoGar6
Dr Eltenemy presenting on his series is k and spk robotic transplants. With 3 d surgical planning, lab experience and practice comprable ischemia time. @DonateLifeEG
Dr Andrew Bentall @AJBentall presenting on ABOi transplants and the importance of precise assessment of blood group antigens and antibodies @MayoTransplant @MayoClinicNeph @DonateLifeEG
Dr Martin Mai presenting on biomarkers in kidney transplantation. “ personalised care is hare’ @MayoTransplant @MayoClinicNeph @DonateLifeEG
Hatem Amer, MD, FASN, FAST retweeted
👏 So proud to see our Mayo Clinic Nephrology fellows deliver outstanding oral and poster presentations at American Society of Nephrology #KidneyWk 2025 — showcasing excellence, innovation, and collaboration.
🙏🏻 Thanks 😊 @ASNKidney
@Arjun_Mohan1 @h4amer @k1dneyMD @wisit661
Dr Sandra Herrman @HerrmannMd presenting at ASN on TMA/complement and anti complement therapies in cancer patients. @MayoClinicNeph @MayoClinic @MayoTransplant
Hatem Amer, MD, FASN, FAST retweeted
Excited to share our recently published case report on RAS. Highlighting the potential role of revascularization in select high-risk cases 🫘 👏🏽
Thanks for the opportunity and guidance @SamyRiad9 @MayoClinicNeph
doi.org/10.47487/apcyccv.v6i…




























